Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Now there is renewed hope for adults with partial-onset (focal) epilepsy — including those with two or more seizure foci.
Medtronic deep brain stimulation (DBS) is a clinically-proven, full-body MR conditional* therapy for bilateral anterior thalamic nucleus stimulation, and is indicated as an adjunctive therapy to significantly reduce seizure frequency and severity for medically refractory patients with epilepsy — for better outcomes, and improved quality of life.
Complete this short questionnaire to help determine whether you are a candidate for Medtronic DBS therapy for epilepsy.
*Indicates required field.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions.